Evidence map›Paper›PMID 33104760›Full record

ArticlePLoS pathogens2020

MAVS regulates the quality of the antibody response to West-Nile Virus.

Marvin O'Ketch, Spencer Williams, Cameron Larson, Jennifer L Uhrlaub, Rachel Wong, Brenna Hall, Neha R Deshpande, Dominik Schenten

Open access · goldAbstract read
In one paragraph

Article in PLoS pathogens, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.1field-weighted citation impact, top 56% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. West Nile virus unmasked: from gene variability to future challenges.Frontiers in cellular and infection microbiology · 2025
    Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Marvin O'KetchDepartment of Immunobiology, University of Arizona, Tucson, Arizona, United States of America.
Spencer WilliamsDepartment of Immunobiology, University of Arizona, Tucson, Arizona, United States of America.ORCID 0000-0003-4601-9201
Cameron LarsonDepartment of Immunobiology, University of Arizona, Tucson, Arizona, United States of America.ORCID 0000-0002-7947-6436
Jennifer L UhrlaubDepartment of Immunobiology, University of Arizona, Tucson, Arizona, United States of America.ORCID 0000-0002-7745-0179
Rachel WongDepartment of Immunobiology, University of Arizona, Tucson, Arizona, United States of America.ORCID 0000-0001-7837-2881
Brenna HallDepartment of Immunobiology, University of Arizona, Tucson, Arizona, United States of America.ORCID 0000-0001-7103-2112
Neha R DeshpandeDepartment of Immunobiology, University of Arizona, Tucson, Arizona, United States of America.
Dominik SchentenDepartment of Immunobiology, University of Arizona, Tucson, Arizona, United States of America.ORCID 0000-0001-7585-0745
University of Arizona · US

Funding

Quality Control of Antibody Responses by the Innate Signaling Adaptor MAVSR21AI146388 · NIAID · UNIVERSITY OF ARIZONA · PI SCHENTEN, DOMINIK · 2020 to 2021
$422k
Mechanisms of Rig-I-like receptor (RLR)-dependent regulation of humoral immunityR56AI130044 · NIAID · UNIVERSITY OF ARIZONA · PI SCHENTEN, DOMINIK · 2018 to 2018
$302k
NIAID NIH HHS R21 AI146388NIAID NIH HHS R56 AI130044
6 · The paper itself

Abstract

A key difference that distinguishes viral infections from protein immunizations is the recognition of viral nucleic acids by cytosolic pattern recognition receptors (PRRs). Insights into the functions of cytosolic PRRs such as the RNA-sensing Rig-I-like receptors (RLRs) in the instruction of adaptive immunity are therefore critical to understand protective immunity to infections. West Nile virus (WNV) infection of mice deficent of RLR-signaling adaptor MAVS results in a defective adaptive immune response. While this finding suggests a role for RLRs in the instruction of adaptive immunity to WNV, it is difficult to interpret due to the high WNV viremia, associated exessive antigen loads, and pathology in the absence of a MAVS-dependent innate immune response. To overcome these limitations, we have infected MAVS-deficient (MAVSKO) mice with a single-round-of-infection mutant of West Nile virus. We show that MAVSKO mice failed to produce an effective neutralizing antibody response to WNV despite normal antibody titers against the viral WNV-E protein. This defect occurred independently of antigen loads or overt pathology. The specificity of the antibody response in infected MAVSKO mice remained unchanged and was still dominated by antibodies that bound the neutralizing lateral ridge (LR) epitope in the DIII domain of WNV-E. Instead, MAVSKO mice produced IgM antibodies, the dominant isotype controlling primary WNV infection, with lower affinity for the DIII domain. Our findings suggest that RLR-dependent signals are important for the quality of the humoral immune response to WNV.

Indexed as

Adaptive ImmunityAdaptor Proteins, Signal TransducingAnimalsAntibodies, NeutralizingAntibodies, ViralAntibody FormationDEAD Box Protein 58FemaleImmunity, HumoralImmunity, InnateImmunoglobulin MMaleMiceMice, Inbred C57BLMice, KnockoutReceptors, Pattern RecognitionAdaptor Proteins, Signal TransducingAntibodies, NeutralizingAntibodies, ViralDEAD Box Protein 58Immunoglobulin MMAVS protein, mouseReceptors, Pattern Recognition

Identifiers

PMID33104760
PMCPMC7644103
OpenAlexW3094197186

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.